Mediators of Inflammation (Jan 2002)

In vitro effects of fluticasone propionate on IL-13 production by mitogen-stimulated lymphocytes

  • Gabriele Di Lorenzo,
  • Maria Luisa Pacor,
  • Maria Esposito Pellitteri,
  • Sebastiano Gangemi,
  • Patrizia Di Blasi,
  • Giuseppina Candore,
  • Alfredo Colombo,
  • Domenico Lio,
  • Calogero Caruso

DOI
https://doi.org/10.1080/09622935020138226
Journal volume & issue
Vol. 11, no. 3
pp. 187 – 190

Abstract

Read online

Background: Corticosteroid administration produces multiple immunomodulatory effects, including down-regulation of cytokine production by CD4 T lymphocytes. Fluticasone propionate (FP) (Glaxo Smith&Kline, Greenford, UK), a highly lipophilic topical corticosteroid, has been shown to be safe and effective in the treatment of asthma and of both seasonal and perennial rhinitis.